CLEAR CELL ADENOCARCINOMA
Clinical trials for CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to extend life in recurrent ovarian cancer
Disease control OngoingThis study looked at whether adding the drug bevacizumab to standard chemotherapy after surgery helps people with recurrent ovarian, peritoneal, or fallopian tube cancer live longer. Over 1,000 participants were randomly assigned to receive chemo alone or chemo plus bevacizumab, …
Matched conditions: CLEAR CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Immunotherapy duo takes on rare, tough ovarian cancer
Disease control OngoingThis study tests whether the immunotherapy drug nivolumab, alone or combined with ipilimumab, can shrink tumors in people with advanced clear cell carcinoma of the ovary, fallopian tube, peritoneum, or other organs. About 46 participants with recurrent or metastatic disease will …
Matched conditions: CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 20, 2026 11:55 UTC